233 related articles for article (PubMed ID: 32330428)
1. Hospital-based use of thromboprophylaxis in patients with COVID-19.
Spyropoulos AC; Ageno W; Barnathan ES
Lancet; 2020 May; 395(10234):e75. PubMed ID: 32330428
[No Abstract] [Full Text] [Related]
2. Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.
Di Micco P; Russo V; Lodigiani C
Medicina (Kaunas); 2020 Sep; 56(10):. PubMed ID: 32992511
[TBL] [Abstract][Full Text] [Related]
3. [Venous thromboembolism in patients with COVID-19].
Hellfritzsch M; Kümler T; Hansen AT; Tang M; Berthelsen KG; Fialla AD; Andersen AS; Kampmann P; Hvas AM
Ugeskr Laeger; 2020 Jun; 182(23):. PubMed ID: 32515339
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M
Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132
[No Abstract] [Full Text] [Related]
5. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?
Dutt T; Simcox D; Downey C; McLenaghan D; King C; Gautam M; Lane S; Burhan H
Am J Respir Crit Care Med; 2020 Aug; 202(3):455-457. PubMed ID: 32510975
[No Abstract] [Full Text] [Related]
7. Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".
Marietta M; Tripodi A
Blood Transfus; 2020 May; 18(3):239-240. PubMed ID: 32453693
[No Abstract] [Full Text] [Related]
8. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
Ferrandis R; Llau JV; Quintana M; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A
Crit Care; 2020 Jun; 24(1):332. PubMed ID: 32527286
[No Abstract] [Full Text] [Related]
9. Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.
Cattaneo M; Morici N
Blood Transfus; 2020 May; 18(3):237-238. PubMed ID: 32453692
[No Abstract] [Full Text] [Related]
10. Arterial thrombosis and coronavirus disease 2019 in a patient with cancer.
Nassabein R; Routy B; Blais N; Ayoub JP; Tehfé M
Eur J Cancer; 2020 Jul; 134():1-2. PubMed ID: 32454394
[No Abstract] [Full Text] [Related]
11. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
Kumar P; Mediwake R; Rhead C
Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
[No Abstract] [Full Text] [Related]
12. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
Linnemann B; Bauersachs R; Grebe M; Klamroth R; Müller O; Schellong S; Lichtenberg M
Vasa; 2020 Jun; 49(4):259-263. PubMed ID: 32501145
[No Abstract] [Full Text] [Related]
13. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease.
Siegal DM; Gross PL
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1958-1960. PubMed ID: 32762455
[No Abstract] [Full Text] [Related]
14. Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019.
Piagnerelli M; Cauchie P; Wautrecht JC
Crit Care Med; 2020 Oct; 48(10):e988-e989. PubMed ID: 32706558
[No Abstract] [Full Text] [Related]
15. COVID-19 and venous thromboembolism - prophylaxis and treatment.
Kvåle R; Azrakhsh NA; Mohn KG; Aanerud M; Guttormsen AB; Reikvam H
Tidsskr Nor Laegeforen; 2020 Aug; 140(11):. PubMed ID: 32815357
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and hypercoagulability in the outpatient setting.
Emert R; Shah P; Zampella JG
Thromb Res; 2020 Aug; 192():122-123. PubMed ID: 32473495
[No Abstract] [Full Text] [Related]
17. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.
Coppola A; Lombardi M; Tassoni MI; Carolla G; Tala M; Morandini R; Paoletti O; Testa S
Blood Transfus; 2020 May; 18(3):226-229. PubMed ID: 32453688
[No Abstract] [Full Text] [Related]
18. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
[TBL] [Abstract][Full Text] [Related]
19. Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.
Spyropoulos AC; Weitz JI
Circulation; 2020 Jul; 142(2):129-132. PubMed ID: 32658609
[No Abstract] [Full Text] [Related]
20. Thrombosis and COVID-19 pneumonia: the clot thickens!
Price LC; McCabe C; Garfield B; Wort SJ
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32554532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
